Daniel D. Murray

Medicine & Life Sciences

1. GS-5734 100%
2. HIV 82%
3. Viral Load 61%
4. Placebos 58%
5. SARS Virus 57%
6. Biomarkers 53%
7. Gastrointestinal Microbiome 47%
8. HIV Infections 46%
9. Inpatients 45%
10. Coronavirus 44%
11. Neutralizing Antibodies 41%
12. Hematopoietic Stem Cell Transplantation 39%
13. aviptadil 36%
14. Infections 35%
15. Randomized Controlled Trials 34%
16. Medical Futility 34%
17. Therapeutics 33%
18. HIV-1 32%
19. HLA Antigens 32%
20. Alleles 31%
21. Metabolic Syndrome 30%
22. Safety 29%
23. baricitinib 29%
24. Monoclonal Antibodies 28%
25. Genetic Load 26%
26. Machine Learning 25%
27. Vaccines 25%
28. Lipidomics 24%
29. CD4 Lymphocyte Count 23%
30. Metabolomics 23%
31. Dioxygenases 22%
32. Single Nucleotide Polymorphism 22%
33. C-Reactive Protein 22%
34. Circulating MicroRNA 22%
35. Firearms 22%
36. Primary Immunodeficiency Diseases 21%
37. Metagenomics 21%
38. Procalcitonin 20%
39. Confidence Intervals 19%
40. Exome 19%
41. Precision Medicine 19%
42. Whole Genome Sequencing 18%
43. Acute Lung Injury 18%
44. Dengue 18%
45. Intravenous Immunoglobulins 17%
46. Incidence 17%
47. Glutamic Acid 17%
48. Epitopes 17%
49. Population 16%
50. rRNA Genes 16%